Places
Home
Graphs
Prefixes
Admin
Users
Settings
Plugins
Statistics
Repository
Load local file
Load from HTTP
Load from library
Remove triples
Clear repository
Query
YASGUI SPARQL Editor
Simple Form
SWISH Prolog shell
Help
Documentation
Tutorial
Roadmap
HTTP Services
Login
Local view for "http://liddi.stanford.edu/LIDDI:SID2977"
Predicate
Value (sorted:
none
)
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between tramadol and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID1324_SID2977_EID4962]
35
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and gemcitabine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1423_EID0002]
88
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between tramadol and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID1324_SID2977_EID4966]
36
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and imatinib - Event - Arrhythmia. [LIDDI_resource:SID2977_SID3431_EID4966]
119
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and lidocaine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0742_EID0002]
76
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between theophylline and daclizumab - Event - Neutropenia. [LIDDI_resource:SID1285_SID2977_EID4963]
34
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between moxifloxacin and daclizumab - Event - Bradycardia. [LIDDI_resource:SID2918_SID2977_EID4970]
56
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between cinacalcet and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID4039_SID2977_EID0002]
130
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between prednisone and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID1092_SID2977_EID4966]
30
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between topotecan and daclizumab - Event - Neutropenia. [LIDDI_resource:SID2504_SID2977_EID4963]
48
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and topotecan - Event - Neutropenia. [LIDDI_resource:SID2977_SID2504_EID4963]
103
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and estradiol - Event - Neutropenia. [LIDDI_resource:SID2977_SID0491_EID4963]
69
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between vinblastine and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID1386_SID2977_EID0002]
37
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and vinblastine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1386_EID0002]
84
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between baclofen and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0132_SID2977_EID4971]
4
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between ganciclovir and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID0584_SID2977_EID4966]
17
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between ifosfamide and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0662_SID2977_EID4970]
20
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and cefepime - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1603_EID0002]
90
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and pregabalin - Event - Neutropenia. [LIDDI_resource:SID2977_SID2976_EID4963]
115
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and haloperidol - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0619_EID4966]
74
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and mometasone - Event - Neutropenia. [LIDDI_resource:SID2977_SID2832_EID4963]
112
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between rofecoxib and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID3077_SID2977_EID4965]
126
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between nitrofurantoin and daclizumab - Event - Neutropenia. [LIDDI_resource:SID0912_SID2977_EID4963]
25
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between nystatin and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID0930_SID2977_EID4966]
27
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between terbinafine and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID2213_SID2977_EID0003]
42
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and tamoxifen - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID1269_EID4959]
82
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and ibuprofen - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID0658_EID4959]
75
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between bumetanide and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0185_SID2977_EID4965]
5
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between hydralazine and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0640_SID2977_EID4970]
19
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between midazolam and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0855_SID2977_EID4971]
23
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between temozolomide and daclizumab - Event - Arrhythmia. [LIDDI_resource:SID2210_SID2977_EID4966]
41
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between anastrozole and daclizumab - Event - Bradycardia. [LIDDI_resource:SID2694_SID2977_EID4970]
54
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and trastuzumab - Event - Neutropenia. [LIDDI_resource:SID2977_SID3058_EID4963]
116
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and clonazepam - Event - Pancytopenia. [LIDDI_resource:SID2977_SID0317_EID4962]
63
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and midazolam - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID0855_EID4971]
77
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and paricalcitol - Event - Arrhythmia. [LIDDI_resource:SID2977_SID2642_EID4966]
108
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and repaglinide - Event - Neutropenia. [LIDDI_resource:SID2977_SID2632_EID4963]
107
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and cefepime - Event - Bradycardia. [LIDDI_resource:SID2977_SID1603_EID4970]
91
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between amiloride and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID0077_SID2977_EID0003]
1
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between calcitriol and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0199_SID2977_EID0002]
6
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between clotrimazole and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0325_SID2977_EID4970]
9
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between doxycycline and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0462_SID2977_EID4965]
14
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between droperidol and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0464_SID2977_EID4971]
15
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between ketoconazole and daclizumab - Event - Neutropenia. [LIDDI_resource:SID0722_SID2977_EID4963]
21
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and theophylline - Event - Neutropenia. [LIDDI_resource:SID2977_SID1285_EID4963]
83
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and entacapone - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID2538_EID4971]
105
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and colchicine - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0333_EID4966]
65
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and warfarin - Event - Pancytopenia. [LIDDI_resource:SID2977_SID1397_EID4962]
85
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and foscarnet - Event - Neutropenia. [LIDDI_resource:SID2977_SID2057_EID4963]
93
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between zonisamide and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID2304_SID2977_EID0003]
44
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between goserelin and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID2426_SID2977_EID4962]
47
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between lamivudine and daclizumab - Event - Bradycardia. [LIDDI_resource:SID2582_SID2977_EID4970]
51
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between pregabalin and daclizumab - Event - Neutropenia. [LIDDI_resource:SID2976_SID2977_EID4963]
57
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and cefuroxime - Event - Neutropenia. [LIDDI_resource:SID2977_SID0253_EID4963]
62
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and nystatin - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0930_EID0002]
78
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and nateglinide - Event - Arrhythmia. [LIDDI_resource:SID2977_SID3414_EID4966]
117
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and ganciclovir - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0584_EID4966]
71
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between azathioprine and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0128_SID2977_EID0002]
3
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between diphenoxylate and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0446_SID2977_EID4965]
13
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and fluvastatin - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2321_EID0003]
99
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and goserelin - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID2426_EID4959]
102
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and glucosamine - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID0598_EID0003]
72
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and rabeprazole - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2853_EID0003]
113
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and voriconazole - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID2873_EID4971]
114
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and escitalopram - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID3823_EID0002]
120
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and latanoprost - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2371_EID0003]
100
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and temozolomide - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID2210_EID0002]
95
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and azathioprine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0128_EID0002]
58
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between amiodarone and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0084_SID2977_EID4965]
2
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between diclofenac and daclizumab - Event - Parkinsonism. [LIDDI_resource:SID0412_SID2977_EID4965]
11
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between megestrol and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0786_SID2977_EID4971]
22
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between ranitidine and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID1155_SID2977_EID4962]
31
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between foscarnet and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2057_SID2977_EID4971]
40
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and sitagliptin - Event - Neutropenia. [LIDDI_resource:SID2977_SID4107_EID4963]
123
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and tazobactam - Event - Pancytopenia. [LIDDI_resource:SID2977_SID2205_EID4962]
94
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and cefazolin - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0241_EID0002]
60
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and bumetanide - Event - Parkinsonism. [LIDDI_resource:SID2977_SID0185_EID4965]
59
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between rosuvastatin and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID3546_SID2977_EID0003]
128
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between cefotaxime and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID0245_SID2977_EID4971]
7
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between pentostatin and daclizumab - Event - Pancytopenia. [LIDDI_resource:SID0990_SID2977_EID4962]
28
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between entacapone and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2538_SID2977_EID4971]
50
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between pemetrexed and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2584_SID2977_EID4971]
52
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and tamsulosin - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID2654_EID0002]
109
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and zidovudine - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1407_EID0002]
86
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and zidovudine - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID1407_EID4971]
87
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and cefotaxime - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID0245_EID4971]
61
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and ezetimibe - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID3874_EID0003]
121
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and glucosamine - Event - Parkinsonism. [LIDDI_resource:SID2977_SID0598_EID4965]
73
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and hydromorphone - Event - Arrhythmia. [LIDDI_resource:SID2977_SID0431_EID4966]
68
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between valganciclovir and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID3421_SID2977_EID4971]
127
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between nortriptyline and daclizumab - Event - Bradycardia. [LIDDI_resource:SID0925_SID2977_EID4970]
26
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between gemcitabine and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID1423_SID2977_EID0002]
39
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and zonisamide - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2304_EID0003]
98
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between candesartan and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID3007_SID2977_EID0002]
124
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between entacapone and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID2538_SID2977_EID4964]
49
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and bortezomib - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID4002_EID4964]
122
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between tamoxifen and daclizumab - Event - Long QT syndrome. [LIDDI_resource:SID1269_SID2977_EID4959]
33
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between pantoprazole and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID2318_SID2977_EID0002]
45
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between fluvastatin and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID2321_SID2977_EID0003]
46
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between voriconazole and daclizumab - Event - Hyperkalaemia. [LIDDI_resource:SID2873_SID2977_EID4971]
55
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and terbinafine - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2213_EID0003]
96
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between rofecoxib and daclizumab - Event - Long QT syndrome. [LIDDI_resource:SID3077_SID2977_EID4959]
125
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between escitalopram and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID3823_SID2977_EID0002]
129
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between cyclophosphamide and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0358_SID2977_EID0002]
10
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and latanoprost - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2371_EID4964]
101
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and cyclophosphamide - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0358_EID0002]
66
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between warfarin and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID1397_SID2977_EID4964]
38
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and daunorubicin - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID0373_EID0003]
67
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and itraconazole - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID1877_EID0003]
92
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and atorvastatin - Event - Rhabdomyolysis. [LIDDI_resource:SID2977_SID2682_EID0003]
110
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between clotrimazole and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID0325_SID2977_EID4964]
8
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between piperacillin and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID1046_SID2977_EID4964]
29
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between hydromorphone and daclizumab - Event - Rhabdomyolysis. [LIDDI_resource:SID0431_SID2977_EID0003]
12
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between minoxidil and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID0860_SID2977_EID4964]
24
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and valganciclovir - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID3421_EID4971]
118
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between sitagliptin and daclizumab - Event - Long QT syndrome. [LIDDI_resource:SID4107_SID2977_EID4959]
131
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between fludrocortisone and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID0547_SID2977_EID0002]
16
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and fludrocortisone - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID0547_EID0002]
70
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and entacapone - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2538_EID4964]
104
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and atorvastatin - Event - Long QT syndrome. [LIDDI_resource:SID2977_SID2682_EID4959]
111
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between haloperidol and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID0619_SID2977_EID4964]
18
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between sulfamethoxazole and daclizumab - Event - Hypoglycaemia. [LIDDI_resource:SID1247_SID2977_EID0002]
32
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between terbinafine and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID2213_SID2977_EID4964]
43
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and terbinafine - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2213_EID4964]
97
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and propylthiouracil - Event - Hyperkalaemia. [LIDDI_resource:SID2977_SID1124_EID4971]
80
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and sulfamethoxazole - Event - Hypoglycaemia. [LIDDI_resource:SID2977_SID1247_EID0002]
81
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between troglitazone and daclizumab - Event - Serotonin syndrome. [LIDDI_resource:SID2624_SID2977_EID4964]
53
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and clotrimazole - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID0325_EID4964]
64
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and piperacillin - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID1046_EID4964]
79
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and azithromycin - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID1513_EID4964]
89
dv
:
drugbank_vocabulary:ddi-interactor-in
ddir
:
DDI between daclizumab and troglitazone - Event - Serotonin syndrome. [LIDDI_resource:SID2977_SID2624_EID4964]
106
Named graphs describing this resource:
1
http://liddi.stanford.edu/LIDDI_resource:SID0077_SID2977_EID0003_nanopubassertion
2
http://liddi.stanford.edu/LIDDI_resource:SID0084_SID2977_EID4965_nanopubassertion
3
http://liddi.stanford.edu/LIDDI_resource:SID0128_SID2977_EID0002_nanopubassertion
4
http://liddi.stanford.edu/LIDDI_resource:SID0132_SID2977_EID4971_nanopubassertion
5
http://liddi.stanford.edu/LIDDI_resource:SID0185_SID2977_EID4965_nanopubassertion
6
http://liddi.stanford.edu/LIDDI_resource:SID0199_SID2977_EID0002_nanopubassertion
7
http://liddi.stanford.edu/LIDDI_resource:SID0245_SID2977_EID4971_nanopubassertion
8
http://liddi.stanford.edu/LIDDI_resource:SID0325_SID2977_EID4964_nanopubassertion
9
http://liddi.stanford.edu/LIDDI_resource:SID0325_SID2977_EID4970_nanopubassertion
10
http://liddi.stanford.edu/LIDDI_resource:SID0358_SID2977_EID0002_nanopubassertion
11
http://liddi.stanford.edu/LIDDI_resource:SID0412_SID2977_EID4965_nanopubassertion
12
http://liddi.stanford.edu/LIDDI_resource:SID0431_SID2977_EID0003_nanopubassertion
13
http://liddi.stanford.edu/LIDDI_resource:SID0446_SID2977_EID4965_nanopubassertion
14
http://liddi.stanford.edu/LIDDI_resource:SID0462_SID2977_EID4965_nanopubassertion
15
http://liddi.stanford.edu/LIDDI_resource:SID0464_SID2977_EID4971_nanopubassertion
16
http://liddi.stanford.edu/LIDDI_resource:SID0547_SID2977_EID0002_nanopubassertion
17
http://liddi.stanford.edu/LIDDI_resource:SID0584_SID2977_EID4966_nanopubassertion
18
http://liddi.stanford.edu/LIDDI_resource:SID0619_SID2977_EID4964_nanopubassertion
19
http://liddi.stanford.edu/LIDDI_resource:SID0640_SID2977_EID4970_nanopubassertion
20
http://liddi.stanford.edu/LIDDI_resource:SID0662_SID2977_EID4970_nanopubassertion
21
http://liddi.stanford.edu/LIDDI_resource:SID0722_SID2977_EID4963_nanopubassertion
22
http://liddi.stanford.edu/LIDDI_resource:SID0786_SID2977_EID4971_nanopubassertion
23
http://liddi.stanford.edu/LIDDI_resource:SID0855_SID2977_EID4971_nanopubassertion
24
http://liddi.stanford.edu/LIDDI_resource:SID0860_SID2977_EID4964_nanopubassertion
25
http://liddi.stanford.edu/LIDDI_resource:SID0912_SID2977_EID4963_nanopubassertion
26
http://liddi.stanford.edu/LIDDI_resource:SID0925_SID2977_EID4970_nanopubassertion
27
http://liddi.stanford.edu/LIDDI_resource:SID0930_SID2977_EID4966_nanopubassertion
28
http://liddi.stanford.edu/LIDDI_resource:SID0990_SID2977_EID4962_nanopubassertion
29
http://liddi.stanford.edu/LIDDI_resource:SID1046_SID2977_EID4964_nanopubassertion
30
http://liddi.stanford.edu/LIDDI_resource:SID1092_SID2977_EID4966_nanopubassertion
31
http://liddi.stanford.edu/LIDDI_resource:SID1155_SID2977_EID4962_nanopubassertion
32
http://liddi.stanford.edu/LIDDI_resource:SID1247_SID2977_EID0002_nanopubassertion
33
http://liddi.stanford.edu/LIDDI_resource:SID1269_SID2977_EID4959_nanopubassertion
34
http://liddi.stanford.edu/LIDDI_resource:SID1285_SID2977_EID4963_nanopubassertion
35
http://liddi.stanford.edu/LIDDI_resource:SID1324_SID2977_EID4962_nanopubassertion
36
http://liddi.stanford.edu/LIDDI_resource:SID1324_SID2977_EID4966_nanopubassertion
37
http://liddi.stanford.edu/LIDDI_resource:SID1386_SID2977_EID0002_nanopubassertion
38
http://liddi.stanford.edu/LIDDI_resource:SID1397_SID2977_EID4964_nanopubassertion
39
http://liddi.stanford.edu/LIDDI_resource:SID1423_SID2977_EID0002_nanopubassertion
40
http://liddi.stanford.edu/LIDDI_resource:SID2057_SID2977_EID4971_nanopubassertion
41
http://liddi.stanford.edu/LIDDI_resource:SID2210_SID2977_EID4966_nanopubassertion
42
http://liddi.stanford.edu/LIDDI_resource:SID2213_SID2977_EID0003_nanopubassertion
43
http://liddi.stanford.edu/LIDDI_resource:SID2213_SID2977_EID4964_nanopubassertion
44
http://liddi.stanford.edu/LIDDI_resource:SID2304_SID2977_EID0003_nanopubassertion
45
http://liddi.stanford.edu/LIDDI_resource:SID2318_SID2977_EID0002_nanopubassertion
46
http://liddi.stanford.edu/LIDDI_resource:SID2321_SID2977_EID0003_nanopubassertion
47
http://liddi.stanford.edu/LIDDI_resource:SID2426_SID2977_EID4962_nanopubassertion
48
http://liddi.stanford.edu/LIDDI_resource:SID2504_SID2977_EID4963_nanopubassertion
49
http://liddi.stanford.edu/LIDDI_resource:SID2538_SID2977_EID4964_nanopubassertion
50
http://liddi.stanford.edu/LIDDI_resource:SID2538_SID2977_EID4971_nanopubassertion
51
http://liddi.stanford.edu/LIDDI_resource:SID2582_SID2977_EID4970_nanopubassertion
52
http://liddi.stanford.edu/LIDDI_resource:SID2584_SID2977_EID4971_nanopubassertion
53
http://liddi.stanford.edu/LIDDI_resource:SID2624_SID2977_EID4964_nanopubassertion
54
http://liddi.stanford.edu/LIDDI_resource:SID2694_SID2977_EID4970_nanopubassertion
55
http://liddi.stanford.edu/LIDDI_resource:SID2873_SID2977_EID4971_nanopubassertion
56
http://liddi.stanford.edu/LIDDI_resource:SID2918_SID2977_EID4970_nanopubassertion
57
http://liddi.stanford.edu/LIDDI_resource:SID2976_SID2977_EID4963_nanopubassertion
58
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0128_EID0002_nanopubassertion
59
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0185_EID4965_nanopubassertion
60
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0241_EID0002_nanopubassertion
61
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0245_EID4971_nanopubassertion
62
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0253_EID4963_nanopubassertion
63
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0317_EID4962_nanopubassertion
64
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0325_EID4964_nanopubassertion
65
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0333_EID4966_nanopubassertion
66
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0358_EID0002_nanopubassertion
67
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0373_EID0003_nanopubassertion
68
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0431_EID4966_nanopubassertion
69
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0491_EID4963_nanopubassertion
70
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0547_EID0002_nanopubassertion
71
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0584_EID4966_nanopubassertion
72
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0598_EID0003_nanopubassertion
73
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0598_EID4965_nanopubassertion
74
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0619_EID4966_nanopubassertion
75
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0658_EID4959_nanopubassertion
76
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0742_EID0002_nanopubassertion
77
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0855_EID4971_nanopubassertion
78
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID0930_EID0002_nanopubassertion
79
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1046_EID4964_nanopubassertion
80
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1124_EID4971_nanopubassertion
81
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1247_EID0002_nanopubassertion
82
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1269_EID4959_nanopubassertion
83
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1285_EID4963_nanopubassertion
84
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1386_EID0002_nanopubassertion
85
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1397_EID4962_nanopubassertion
86
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1407_EID0002_nanopubassertion
87
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1407_EID4971_nanopubassertion
88
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1423_EID0002_nanopubassertion
89
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1513_EID4964_nanopubassertion
90
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1603_EID0002_nanopubassertion
91
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1603_EID4970_nanopubassertion
92
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID1877_EID0003_nanopubassertion
93
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2057_EID4963_nanopubassertion
94
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2205_EID4962_nanopubassertion
95
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2210_EID0002_nanopubassertion
96
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2213_EID0003_nanopubassertion
97
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2213_EID4964_nanopubassertion
98
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2304_EID0003_nanopubassertion
99
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2321_EID0003_nanopubassertion
100
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2371_EID0003_nanopubassertion
101
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2371_EID4964_nanopubassertion
102
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2426_EID4959_nanopubassertion
103
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2504_EID4963_nanopubassertion
104
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2538_EID4964_nanopubassertion
105
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2538_EID4971_nanopubassertion
106
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2624_EID4964_nanopubassertion
107
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2632_EID4963_nanopubassertion
108
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2642_EID4966_nanopubassertion
109
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2654_EID0002_nanopubassertion
110
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2682_EID0003_nanopubassertion
111
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2682_EID4959_nanopubassertion
112
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2832_EID4963_nanopubassertion
113
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2853_EID0003_nanopubassertion
114
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2873_EID4971_nanopubassertion
115
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID2976_EID4963_nanopubassertion
116
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID3058_EID4963_nanopubassertion
117
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID3414_EID4966_nanopubassertion
118
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID3421_EID4971_nanopubassertion
119
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID3431_EID4966_nanopubassertion
120
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID3823_EID0002_nanopubassertion
121
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID3874_EID0003_nanopubassertion
122
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID4002_EID4964_nanopubassertion
123
http://liddi.stanford.edu/LIDDI_resource:SID2977_SID4107_EID4963_nanopubassertion
124
http://liddi.stanford.edu/LIDDI_resource:SID3007_SID2977_EID0002_nanopubassertion
125
http://liddi.stanford.edu/LIDDI_resource:SID3077_SID2977_EID4959_nanopubassertion
126
http://liddi.stanford.edu/LIDDI_resource:SID3077_SID2977_EID4965_nanopubassertion
127
http://liddi.stanford.edu/LIDDI_resource:SID3421_SID2977_EID4971_nanopubassertion
128
http://liddi.stanford.edu/LIDDI_resource:SID3546_SID2977_EID0003_nanopubassertion
129
http://liddi.stanford.edu/LIDDI_resource:SID3823_SID2977_EID0002_nanopubassertion
130
http://liddi.stanford.edu/LIDDI_resource:SID4039_SID2977_EID0002_nanopubassertion
131
http://liddi.stanford.edu/LIDDI_resource:SID4107_SID2977_EID4959_nanopubassertion
The resource does not appear as an object
Context graph